Alternatively spliced isoforms of tissue factor pathway inhibitor
MetadataShow full item record
Tissue factor pathway inhibitor (TFPI) is the major regulator of tissue factor (TF)-induced coagulation. It down regulates coagulation by binding to the TF/fVIIa complex in a fXa dependent manner. It is predominantly produced by microvascular endothelial cells, though it is also found in platelets, monocytes, smooth muscle cells, and plasma. Its physiological importance is demonstrated by the embryonic lethality observed in TFPI knockout mice and by the increase in thrombotic burden that occurs when heterozygous TFPI mice are bred with mice carrying genetic risk factors for thrombotic disease, such as factor V Leiden. Multiple TFPI isoforms, termed TFPIa, TFPIß, and TFPId in humans and TFPIa, TFPIß, and TFPI? in mice, have been described, which differ in their domain structure and method for cell surface attachment. A significant functional difference between these isoforms has yet to be described in vivo. Both human and mouse tissues produce, on average, approximately 10 times more TFPIa message when compared to that of TFPIß. Consistent with this finding, several lines of evidence suggest that TFPIa is the predominant protein isoform in humans. In contrast, recent work from our laboratory demonstrates that TFPIß is the major protein isoform produced in adult mice, suggesting that TFPI isoform production is translationally regulated. © 2010 Elsevier Ltd. All rights reserved.
Showing items related by title, author, creator and subject.
Maroney, S.; Ellery, Paul; Wood, J.; Ferrel, J.; Martinez, N.; Mast, A. (2013)Background: Tissue factor pathway inhibitor (TFPI) is an alternatively spliced protein with two isoforms, TFPIa and TFPIß, which differ in their C-terminal structure and cellular localization. Detailed characterization ...
Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-a but not for cell surface-associated tissue factor pathway inhibitorWood, J.; Ellery, Paul; Maroney, S.; Mast, A. (2014)OBJECTIVE - Tissue factor pathway inhibitor (TFPI) is produced in 2 isoforms: TFPIa, a soluble protein in plasma, platelets, and endothelial cells, and TFPIß, a glycosylphosphatidylinositol-anchored protein on endothelium. ...
Translation of human tissue factor pathway inhibitor-ß mRNA is controlled by alternative splicing within the 5' untranslated regionEllery, Paul; Maroney, S.; Martinez, N.; Wickens, M.; Mast, A. (2014)OBJECTIVE - Tissue factor pathway inhibitor (TFPI) blocks the initiation of coagulation by inhibiting TF-activated factor VII, activated factor X, and early prothrombinase. Humans produce two 3' splice variants, TFPIa and ...